73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Long-term pancreatic cancer survivors report excellent post-surgery quality of life

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients

Long-term pancreatic cancer survivors report excellent post-surgery quality of life

by Chloe Corey,Mayo ClinicCredit: Mayo Clinic News NetworkPancreatic cancer is considered the most lethal cancer in the human body. But new treatment advances are improving outcomes for patients
Increased risk of prostate cancer in men with BRCA2 gene fault

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect

Increased risk of prostate cancer in men with BRCA2 gene fault

by Cancer Research UKCredit: CC0 Public DomainMen with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect
New drug could unlock benefits of immunotherapy for more patients

New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen

New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen
Researchers create a drug to extend the lives of men with prostate cancer

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye
Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,

Blood test identifies acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant

byNIH/National Heart, Lung and Blood InstituteDetection and Impact of Residual Variants on Clinical Outcomes by Gene A, Heatmap illustrating for each patient (n = 1075) their cohort assignment,
Scientists find butyrate's possible anticancer potential is cell-type specific

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,

Scientists find butyrate's possible anticancer potential is cell-type specific

FEBRUARY 27, 2024by Maribel Alonso,Agricultural Research ServiceDistinct effects of butyrate on colon cancer cell lines (A) HCT116, (B) HT-29, (C) Caco-2 cell growth curves for 24, 48, and 72 h,
A breast cancer drug, susceptible to resistance, can be restored to effectiveness, researchers demonstrate

A breast cancer drug, susceptible to resistance, can be restored to effectiveness, researchers demonstrate

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainIn a new paperpublishedinCancer Research, researchers at MUSC Hollings Cancer Center have s

A breast cancer drug, susceptible to resistance, can be restored to effectiveness, researchers demonstrate

by Leslie Cantu,Medical University of South CarolinaCredit: Pixabay/CC0 Public DomainIn a new paperpublishedinCancer Research, researchers at MUSC Hollings Cancer Center have s
Discovery could lead to 'kinder' treatment for childhood neuroblastoma

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca

Discovery could lead to 'kinder' treatment for childhood neuroblastoma

by University of CambridgeA ball of neuroblastoma cells forming mature nerves after drug treatment. Credit: Kirsty Ferguson/Developmental CellChildren with neuroblastoma—responsible for 15% of ca
New guideline clarifies role of radiation therapy in pancreatic cancer treatment

New guideline clarifies role of radiation therapy in pancreatic cancer treatment

by American Society for Radiation OncologyAnew clinical guidelinefrom the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to t

New guideline clarifies role of radiation therapy in pancreatic cancer treatment

by American Society for Radiation OncologyAnew clinical guidelinefrom the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to t
Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre
Billions spent on cancer research but only small percentage goes to treatment, study shows

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204
Milestone rating system improved residency knowledge ratings bias

Milestone rating system improved residency knowledge ratings bias

by Elana GotkineAdoption of the Milestone ratings system in 2014 was associated with improvement in internal medicine (IM) residency knowledge ratings bias in Black or Latino residents, who are underr

Milestone rating system improved residency knowledge ratings bias

by Elana GotkineAdoption of the Milestone ratings system in 2014 was associated with improvement in internal medicine (IM) residency knowledge ratings bias in Black or Latino residents, who are underr